Navigation Links
M2S Announces New Addition to Electronic Image Management Offering for Clinical Trials
Date:3/10/2009

M2S Inc., a global provider of image management services for biopharmaceutical and medical device clinical trials, announced today that the company has expanded its electronic image collection and transfer offering with access to AG Mednet, the global HIPAA and 21 CFR Part 11 compliant image exchange network. This enables M2S to offer clinical trial sponsors the ability to choose the optimal image collection and transfer method based on the needs of their particular trial.

(PRWEB) March 10, 2009 -- M2S Inc., a global provider of image management services for biopharmaceutical and medical device clinical trials, announced today that the company has expanded its electronic image collection and transfer offering with access to AG Mednet, the global HIPAA and 21 CFR Part 11 compliant image exchange network. This enables M2S to offer clinical trial sponsors the ability to choose the optimal image collection and transfer method based on the needs of their particular trial.

Clinical trials are increasingly using medical imaging for inclusion criteria, secondary and surrogate endpoints and to serve as adjunctive safety assessment of drugs under development. Clinical trial imaging provides a non-invasive method of obtaining information on a drug's effects in the body and can provide crucial information for making early "go/no-go" decisions, potentially saving millions of dollars in development costs. Collecting and managing large amounts of imaging data securely and rapidly can be challenging and often costly for trial sponsors, and the traditional method of image transfer via hard media and courier services is very time-intensive and error prone. Electronic data transfer of images drastically reduces the time involved, provides the opportunity for early discovery and resolution of queries, and therefore can provide significant cost savings in clinical trials.

"We felt that an agreement with AG Mednet will enable us to optimize the image collection methods for each clinical trial. The AG Mednet solution is a perfect complement to our DICOM ArmorCar® and sFTP image collection tools. In an era of immense cost pressures, we are proud to be the only imaging core lab able to offer rapid and high-quality imaging data through customization of electronic image transfer, while also providing measurable time and cost savings," Wes Chapman, CEO of M2S stated.

Abraham Gutman, President & CEO of AG Mednet added: "We are delighted to be working with M2S. The AG Mednet network platform with its simple to use web-enabled front-end functionality will reduce significantly the number of site queries, while providing M2S with a highly scalable solution to fit the needs of the most demanding global trials."

M2S has been utilizing web-based methods for rapid and secure electronic image collection and transfer since 2002, with their proprietary network transfer device, the DICOM Armor Car (DAC®), which has an installed base of 287 sites worldwide. The AG Mednet network, in use at over 600 investigator sites globally, provides a web-enabled "front-end," allowing sites to de-identify exams, fill electronic transmittal forms and submit the data directly to M2S trial repositories. Whether a trial is a Phase I using imaging for inclusion criteria, or a Phase III multi-center international study with multiple imaging modalities for surrogate endpoints, M2S has the technology and process combination to provide the best customized solution.

About M2S, Inc.
M2S is a full-service imaging CRO, providing high-quality, timely and cost-effective image data management services for clinical trial sponsors in the biopharmaceutical and medical device industries as well as patient registry databases. For the past 10 years, M2S has managed, under protocol, millions of images from around the globe in all major therapeutic areas and in all DICOM modalities. For more information, visit www.m2s.com.

About AG Mednet, Inc.
AG Mednet, Inc. is a global diagnostic imaging network. Pharmaceutical, biotech and medical device companies, core labs and clinical research organizations utilizing imaging technology as part of their trial protocol rely on AG Mednet's automated system to enable the secure electronic transfer of cases from hundreds of locations, enhancing site compliance while providing detailed reporting necessary to meet the most stringent regulatory requirements. Additional information about AG Mednet is available at www.agmednet.com.

# # #

Read the full story at http://www.prweb.com/releases/clinical/tirals/prweb2217894.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Natural Alternatives International, Inc. Announces Carnosyn(R) Beta-Alanine Licensing Agreement
2. ULURU Inc. Announces Senior Management Change
3. Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
4. National Western Life Announces 2008 Fourth Quarter and 2008 Earnings
5. Celebrity Chef Cat Cora Announces First Pregnancy
6. National Patient Advocate Foundation Announces 2009 Elections of Health Policy Leaders to Executive Board of Directors
7. CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa
8. Hooper Holmes Announces Fourth Quarter Earnings Release Date and Conference Call Information
9. Victory Pharma Announces $45 Million Equity Financing
10. Email Fax Provider, EasyLink Services, Announces Prominent Bio-Pharma Signing
11. Pharmos Corporation Announces Receipt of Nasdaq Delisting Determination
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
M2S Announces New Addition to Electronic Image Management Offering for Clinical Trials
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
Breaking Medicine Technology: